This finding indicates that XAF1 plays a key role in the ultimate fate decisions (survival or death) of TMZ-exposed glioma cells, further supporting the usefulness of XAF1 as a prognostic and therapeutic marker for the development of better treatment strategy. The gene discussed is XAF1; the disease is central nervous system cancer.